This is an organized multidisciplinary, integrated program of clinical cancer education aimed at undergraduate students, graduate house staff, post graduates, community physicians, the nursing staff and para-professional groups. A 24-hour curriculum on cancer has been developed for 2nd year students with twenty-six participating faculty from eleven departments. Nineteen (19) electives in cancer are offered to students in both basic and clinical disciplines. Third year students rotate as clinical clerks on cancer services in medicine and surgery. Tumor Boards, Tumor Conferences and Cancer Seminars are aimed at House Staff who also are assigned to clinical cancer services. An ongoing curriculum in cancer nursing prepares the nursing staff for patient management experiences. An active Regional Oncology Program reaches eight community hospitals and is addressing community nursing and para-professional groups as well. Administratively separate sections of Medical, Surgical and Radiation Oncology have been developed, each with a full time oncologic faculty, 3 in medicine, 4 in surgical oncology and 3 in radiotherapy. The oncologic faculty and administrative heads have defined ten (10) educational objectives in oncology. An ongoing evaluation program is in operation to monitor and assess the objectives and program operation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Education Projects (R25)
Project #
5R25CA018019-15
Application #
3451677
Study Section
Clinical Cancer Education Committee (CEC)
Project Start
1975-07-01
Project End
1991-06-30
Budget Start
1989-07-01
Budget End
1991-06-30
Support Year
15
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Boston University
Department
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Toth, B B; Martin, J W; Lippman, S M et al. (1993) Chemoprevention as a form of cancer control. J Am Dent Assoc 124:243-6
Benner, S E; Hong, W K; Lippman, S M et al. (1992) Intermediate biomarkers in upper aerodigestive tract and lung chemoprevention trials. J Cell Biochem Suppl 16G:33-8
Lippman, S M; Lee, J S; Lotan, R et al. (1990) Biomarkers as intermediate end points in chemoprevention trials. J Natl Cancer Inst 82:555-60
Hong, W K; Endicott, J; Itri, L M et al. (1986) 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 315:1501-5
Kavanah, M T; Feldman, M I; Devereux, D F et al. (1985) New surgical approach to minimize radiation-associated small bowel injury in patients with pelvic malignancies requiring surgery and high-dose irradiation. A preliminary report. Cancer 56:1300-4